Stock Details
NVO is Novo Nordisk A/S's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 130.33$. Average daily volumn in 3 months 1.41M. Market cap 310.58B



Stock symbol : NVO. Exchange : NYSE. Currency : USD
Lastest price : 138.09$. Total volume : 1.10M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Novo Nordisk A/S (NVO)
Last Price
138.09$
Change
0.55
Volume
1.10M

Previous Close137.54
Open137.95
Day Range137.57-138.81
Bid0.00 x 1k
Ask0.00 x 1.3k
Volume1.1M
Average Volume1.41M
Market Cap310.58B
Beta0.35
52 Week Range94.75-144.78
Trailing P/E40.61
Foward P/E31.97
Dividend (Yield %)1.16%
Ex-Dividend Date2022-08-12



Financial Details


According to Novo Nordisk A/S's financial reports the company's revenue in 2021 were 140.8B an increase( +11.11%) over the years 2020 revenue that were of 126.95B. In 2021 the company's total earnings were 47.76B while total earnings in 2020 were 42.14B( +11.9%).


Loading ...



Organization

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormon... e replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Market Cap:
310.58B
Revenue:
140.8B
Total Assets:
194.51B
Total Cash:
10.72B


News about "Novo Nordisk A/S"

is-a-beat-on-the-cards-for-novo-nordisk-nvo-in-q4-earnings-image

Is a Beat on the Cards for Novo Nordisk (NVO) in Q4 Earnings?

Source from : YAHOO!Finance - 2 days ago

Novo Nordisk's (NVO) top line is likely to have been driven by sales of its Diabetes and Obesity Care products in the fourth quarter of 2022.See details»


Novo Nordisk A/S Class B (NOVOb)

Source from : Investing - 2 days ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»


Novo Nordisk A/S Series B

Source from : Wall Street Journal - 5 days ago

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»


Novo Nordisk A/S โ€“ Share repurchase programme

Source from : Yahoo Finance - 5 days ago

Bagsvรฆrd, Denmark, 23 January 2023 โ€“ On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...See details»


Do You Think Novo Nordisk A/S (NVO) is an Economically Sensitive Stock?

Source from : Insider Monkey - 15 days ago

Mawer Investment Management highlighted stocks like Novo Nordisk A/S (NYSE:NVO) in the fourth quarter investor letter. Headquartered in Bagsvaerd, Denmark, Novo Nordisk A/S (NYSE:NVO) is a ...See details»


novo-nordisk-as-nvo-and-the-battle-of-fundamentals-vs-technicals-image

Novo Nordisk A/S (NVO) and the Battle of Fundamentals vs. Technicals

Source from : newsheater - 9 days ago

Novo Nordisk A/S (NYSE:NVO) went up by 0.64% from its latest closing price compared to the recent 1-year high of $140.95. The companyโ€™s stock price has collected 6.09% of gains in the last five ...See details»


Novo Nordisk A/S:

Source from : Yahoo News - 1 month ago

Bagsvรฆrd, Denmark, 22 December 2022 โ€“ On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and ...See details»


highlights-from-the-ratings-and-financial-report-for-novo-nordisk-as-nvo-image

Highlights from the Ratings and Financial Report for Novo Nordisk A/S (NVO)

Source from : newsheater - 2 years ago

Novo Nordisk A/S (NYSE:NVO) went down by -0.72% from its latest closing price compared to the recent 1-year high of $144.78. The companyโ€™s stock price has collected -0.62% of loss in the last five ...See details»


Is a Beat on the Cards for Novo Nordisk (NVO) in Q4 Earnings?

Source from : Nasdaq - 2 days ago

Novo Nordisk A/S NVO is scheduled to release its fourth-quarter 2022 results on Feb 1. The companyโ€™s earnings surprise history has been good so far, with its earnings beating the Zacks Consensus ...See details»


Novo Nordisk A/S โ€“ Share repurchase programme

Source from : Yahoo - 11 days ago

Bagsvรฆrd, Denmark, 16 January 2023 โ€“ On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...See details»


Do You Think Novo Nordisk A/S (NVO) is an Economically Sensitive Stock?

Source from : Yahoo! Sports - 16 days ago

Mawer Investment Management highlighted stocks like Novo Nordisk A/S (NYSE:NVO) in the fourth quarter investor letter. Headquartered in Bagsvaerd, Denmark, Novo Nordisk A/S (NYSE:NVO) is a ...See details»


Novo Nordisk A/S:

Source from : Yahoo Finance - 1 month ago

Bagsvรฆrd, Denmark, 22 December 2022 โ€“ On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and ...See details»


Novo Nordisk A/S Share Repurchase Programme

Source from : Mena FN - 6 days ago

Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com , facebook , twitter ...See details»


Novo Nordisk A/S:

Source from : Yahoo News Singapore - 1 month ago

Bagsvรฆrd, Denmark, 22 December 2022 โ€“ On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and ...See details»